Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2019-09-09 AGM Information
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Lumimicro, detailing the date, location, and agenda items (such as articles of incorporation changes and stock exchange approval). This type of document is a standard proxy solicitation or meeting notice, which falls under the Proxy Solicitation & Information Statement category.
2019-09-09 Korean
주권매매거래정지해제(우회상장 미해당)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the KOSDAQ exchange regarding the lifting of a trading suspension for Lumimicro Co., Ltd. It cites specific exchange regulations and provides the effective date for the resumption of trading. Since it is a regulatory announcement regarding market status rather than a financial report, dividend notice, or corporate action, it falls under the general regulatory filing category.
2019-09-09 Korean
전환청구권행사
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (전환사채) issued by Lumimicro. It details the number of shares issued, the conversion price, and the remaining balance of the convertible bonds. This type of corporate action, involving the conversion of debt into equity, falls under capital structure changes and share issuance, which is best classified as Share Issue/Capital Change (SHA).
2019-09-03 Korean
전환청구권행사
Capital/Financing Update Classification · 95% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (전환사채) by Lumimicro. It details the number of shares issued, the conversion price, and the remaining balance of convertible bonds. This type of corporate action, involving the conversion of debt into equity, falls under capital structure changes and share issuance, which is best classified as Share Issue/Capital Change (SHA).
2019-08-20 Korean
전환청구권행사
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds into shares. This involves a change in the company's capital structure as debt is converted into equity, which falls under the category of share issuance or capital changes.
2019-08-19 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Lumimicro Co., Ltd. for the period ending June 30, 2019. It contains comprehensive financial statements, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.